Roquette

Minitablets are an appealing option for an age-appropriate pediatric dosage form. In particular, for combination therapies where multiple active ingredients...

This study aimed to develop and characterize a spray-dried powder aerosol formulation of a commercially available surfactant formulation, Survanta® intratracheal...

Calquence® (crystalline acalabrutinib), a commercially marketed tyrosine kinase inhibitor (TKI), exhibits significantly reduced oral exposure when taken with acid-reducing agents...

Compaction of multiple-unit pellet system (MUPS) tablets has been extensively studied in the past few decades but with marginal success....

Floating drug delivery system of famciclovir was developed to prolong gastric residence time, target stomach mucosa and increase drug bioavailability...

The selection of appropriate functional co-processed excipient (CPE) is a crucial stage in orodispersible minitablets (ODMTs) development. This paper aimed...

Continuous manufacturing is an important element of future manufacturing solutions enabling for both high product quality and streamlined development process....

See the newest publication from Roquette's video blog here Ask the experts: "One way that biopharmaceutical manufacturers can keep up...

Enabling formulations often depend on functional excipients. However, the question remains whether excipients regarded as standard establish similar interactions and...

Tablets constitute about 80–90% of dosage forms commonly prescribed by medical practitioners for therapeutic management of disease conditions. It is...